SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
35 hedge funds and large institutions have $127M invested in Sinovac Biotech, Ltd in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
17% less call options, than puts
Call options by funds: $176K | Put options by funds: $212K
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
35
Holding in Top 10
1
Calls
$176K
Puts
$212K
Top Buyers
| 1 | +$3.35M | |
| 2 | +$2.51M | |
| 3 | +$1.27M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$414K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$241K |
Top Sellers
| 1 | -$2.49M | |
| 2 | -$742K | |
| 3 | -$179K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$174K |
| 5 |
Goldman Sachs
New York
|
-$79K |